Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation

Inhibition of amyloid aggregation is important for developing potential therapeutic strategies of amyloidrelated diseases. Herein, we report that the inhibition effect of a pristine peptide motif (KLVFF) can be significantly improved by introducing a terminal regulatory moiety (terpyridine). The molecular-level observations by using scanning tunneling microscopy reveal stoichiometry-dependent polymorphism of the coassembly structures, which originates from the terminal interactions of peptide with organic modulator moieties and can be attributed to the secondary structures of peptides and conformations of the organic molecules. Furthermore, the polymorphism of the peptide organic coassemblies is shown to be correlated to distinctively different inhibition effects on amyloid-beta 42 (A beta 42) aggregations and cytotoxicity.